Structured Summary
Abstract
A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, VIRGINIAMYCIN FACTOR M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.
MeSH Record
Classification
Broader headings
Narrower headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
6 entry terms
- Virgimycine
- Antibiotic 899
- Eskalin
- Founderguard
- Stajac
- Staphylomycin
MeSH Record
Aspects Covered
26 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
1991(1974);
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Virginiamycin. Medical Subject Headings (MeSH). 2026. Unique ID D014769. http://id.nlm.nih.gov/mesh/2026/D014769
- Virginiamycin. In: Wikipedia. https://en.wikipedia.org/wiki/Virginiamycin
- Virginiamycin. In: Wikidata. https://www.wikidata.org/wiki/Q3560696